Table 1. Genotypes of SD patients analyzed in this study.
Patient | Origin | Age atonset | Age atobservation | Total Hex activity§(% of normal controls) | Genotype* |
SD1 | Italy | 18 m | 10 y+ | 2.8 | [c.626C>T(p.T209I)]+ [c.299+1471_408del2406] |
SD2 | Italy | 4 m | 3y9m+ | 11.5 | [c.1303_1304delGT(p.R435fsX20)]+ [c.926G>T(p.C309F)] |
SD3 | Italy | 6 m | 2y6m+ | 2.6 | [c.1451G>A(p.G484E)]+[?] |
SD4 | Italy | 6 m | 2y3m+ | 3.1 | [c.448A>C(p.T150P)]+ [16Kbdel] |
SD5 | Argentine | 4 m | 2y8m+ | 1.1 | [c.445+1G>A (r.0)]+[c.1451G>A(p.G484E)] |
SD6 | Argentine | 4–6 m | 2y11m+ | 1.3 | [c.445+1G>A (r.0)]+[c.1597C>T(p.R533C)] |
SD7 | Argentine | 4–6 m | 3y4m+ | 4.2 | [c.445+1G>A (r.0)]+[c.1242+1G>A (p.K390_K414delfsX7)] |
SD8 | Argentine | 4–5 m | 3y+ | ND | [c.445+1G>A (r.0)]+[c.1242+1G>A (p.K390_K414delfsX7)] |
SD9 | Argentine | 4–5 m | 3y+ | ND | [c.1082+5G>A(p.G301_W361delfsX10)]+ [c.1601G>A(p.C534Y)] |
SD10 | Brazil | 12 m | 4y2m | 2.8 | [c.1169+5G>A(p.E362_K390del)]+ [c.448A>C(p.T150P)] |
SD11** | Brazil | 8 m | 3y9m | 8.1 | [c.634C>A(p.H212N)]+ [c.634C>A(p.H212N)] |
SD12 | Turkey | 4m | 2y + | NA | [c.1597C>T(p.R533C)]+ [c.1597C>T(p.R533C)] |
SD13 | Bulgaria | 9 m | 1y3m | 1.6 | [c.146C>A(p.S49X)]+ [c.146C>A(p.S49X)] |
SD14 | China | 12 m | 2y | 15 | [c.1260_1265delAGTTGA(p.V421_E422del)]+ [c.1260_1265delAGTTGA(p.V421_E422del)] |
ND: not detectable; NA: not available. Novel mutations are indicated in bold, *RefSeq cDNA:NM_000521. For cDNA numbering +1 corresponds to the A of the first ATG translation initiation codon. RefSeq protein: NP_000512.1. **indicates parents’ consanguinity. m: month; y: years; +deceased; §Owing to the use of different assay methods and tissue samples, total Hex activity values are expressed as a percentage of average control values.